All partnering requests
Private Company
Screening systems to identify stress mitigating botanicals in vitro
  • Background
  • What we're looking for
  • What we can offer you
  • Q&A
Have questions about this request?
Get them answered by the team at the company.
Background

We are a major player and market leader in the consumer health & beauty industry, with a portfolio that spans multiple channels, demographics and categories. We are seeking a preclinical/in vitro screening system/model to identify biological stress-mitigating natural ingredients, compounds, or botanicals. 

 

Systemic and oxidative stress plays a major role in skin and hair health. This is primarily mediated through the body's stress response system, specifically the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. The HPA axis is a complex set of interactions between the hypothalamus, pituitary gland, and adrenal glands. When the body perceives stress, the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH then stimulates the adrenal glands to produce cortisol, a key stress hormone. 

 

At the level of the hair follicle, the expression and presence of elevated cortisol can activate various signaling pathways within the hair follicle cells, leading to changes in gene expression and cellular function. Cortisol can disrupt the normal hair growth cycle, which consists of the anagen (growth), catagen (regression), and telogen (resting) phases. Elevated cortisol levels can prematurely push hair follicles into the telogen phase, a period when the hair follicle is inactive and hair is more likely to fall out. This can lead to a condition called telogen effluvium, where an excessive number of hair follicles enter the telogen phase, resulting in increased hair shedding and noticeable hair thinning.  

 

While various Contract Research Organizations (CROs) offer biochemical and transcriptional measures to detect increased stress in the hair follicle in vitro, a deeper understanding of the larger stress pathway (HPA) would reveal how each mediator and biomarker impacts the hair follicle unit (FU). This understanding could lead to the development of in vitro models using these markers to screen for new compounds that mitigate stress effects on hair health.

What we're looking for

We are seeking high-throughput screening system/model to identify stress-mitigating natural ingredients, compounds, or botanicals through enzymatic inhibition (11β-hydroxysteroid dehydrogenase), receptor interference, activity reduction, and/or gene expression modulation. Solutions of interest include, but are not limited to, in vitro or ex vivo screening models focusing on the options below.

Supporting figures
Reference Figure to the Hair follicle and stress pathway
PNG • 725.83 KB
Solutions of interest include:
  • Models focusing on measurement of the activity of key enzymes involved in glucocorticoid metabolism, such as 11β-hydroxysteroid dehydrogenase
  • Models focusing on gene expression changes related to stress response pathways, such as the HPA axis, unfolded protein response, & oxidative stress response
  • Cell line models: HaCaT keratinocytes, dermal papilla cells, and dermal fibroblasts to measure changes in CRH, ACTH, and cortisol levels, as well as markers of inflammation, vascular function, and hair follicle stem cell quantity and viability.
  • Hair follicle models: ex-vivo human hair follicle cultures to assess the impact of stress on hair follicle biology and stem cell populations.
  • Higher order models: nematode C. elegans to investigate biochemical and transcriptional stress-related endpoints, such as changes in CRH, ACTH levels, DHS-30 (7β-hydroxysteroid dehydrogenase) activity, as well as physiological stress endpoints, including lifespan, thermotolerance, and resistance to oxidative stress.
  • Models focusing on monitoring levels of stress-related metabolites like cortisol, cortisone, & their precursors &metabolites.
Our must-have requirements are:
  • Model(s) capable of high throughput screening for the effect of botanicals or pharmaceuticals in stress response, via in vitro or cell-based systems, measuring either hormonal release or changes in gene expression (transcriptional).

  • Model(s) must be capable of screening a wide variety of chemicals, extracts, etc.

  • Provide a high-level experimental plan with timelines to outline your approach/key milestones.

Our nice-to-have's are:
  • Validated model(s)
  • Demonstrated reproducibility
  • Higher throughput in nature (ability to screen more than 20 materials at a time)
  • High sensitivity (ideal)
  • Time effective - ability to deliver results through testing ingredients in the platform by the end of 2024.
What's out of scope:
  • No animal nor animal-derived models or systems with the exception of C. elegans.
Acceptable technology readiness levels (TRL):
Levels 3-6
What we can offer you
Eligible partnership models:
Sponsored researchCo-developmentLicensing
Benefits:
Sponsored Research
Funding is proposal dependent, but an accepted proposal could expect support in the range of 20,000 - 85,000 USD (milestone dependent) with the potential for follow-on funding.
Expertise
Partners will interact with a project lead to mutually develop a project plan and engage in regular meetings to ensure success. Partners will have access to internal team/experts as appropriate.
Q&A with the company

The Q&A is now closed.

Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Share partnering request
Complete
Refine recommendations
Is this request relevant to you?
Eligible partners
Academic researchersStartups
Seeking partners focused on
AgingAnalytical ChemistryBiochemistryBiomechanicsBiomimeticsBiomolecular ProcessesBiopharmaceuticsBiophysicsBiosensorsBiosystems
37 more

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.